Christopher Straka • UCSD Profiles (original) (raw)

	Title(s)Assistant Clinical Professor, Radiation Medicine and Applied ScienceSchoolVc-health Sciences-schoolsAddress9500 Gilman Drive #La Jolla CA 92093vCardDownload vCard

Biography

Overview

Bibliographic

Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

1. Cost-Effectiveness Analysis of Stereotactic Ablative Radiation Therapy in Patients With Oligometastatic Cancer. Int J Radiat Oncol Biol Phys. 2021 04 01; 109(5):1185-1194. Kumar A, Straka C, Courtney PT, Vitzthum L, Riviere P, Murphy JD. PMID: 33002541.
   View in: PubMed Mentions: 14 Fields:
   Translation:Humans
2. Combined Androgen Blockade in Localized Prostate Cancer Treated With Definitive Radiation Therapy. J Natl Compr Canc Netw. 2019 12; 17(12):1497-1504. Vitzthum LK, Straka C, Sarkar RR, McKay R, Randall JM, Sandhu A, Murphy JD, Rose BS. PMID: 31805534.
   View in: PubMed Mentions: 1 Fields:
   Translation:Humans
3. Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy. Am J Clin Oncol. 2017 Dec; 40(6):612-620. Ying J, Wang CJ, Yan J, Liauw SL, Straka C, Pistenmaa D, Xie XJ, Lotan Y, Roehrborn C, Kim DN. PMID: 26165416.
   View in: PubMed Mentions: 8 Fields:
   Translation:Humans
4. Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1/2 trial. Pract Radiat Oncol. 2017 Jan - Feb; 7(1):e43-e49. Kim DN, Straka C, Cho LC, Lotan Y, Yan J, Kavanagh B, Raben D, Cooley S, Brindle J, Xie XJ, Pistenmaa D, Timmerman R. PMID: 27637137.
   View in: PubMed Mentions: 7 Fields:
   Translation:HumansCTClinical Trials
5. Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome. Springerplus. 2016; 5:229. Straka C, Ying J, Kong FM, Willey CD, Kaminski J, Kim DW. PMID: 27026923; PMCID: PMC4771672.
   View in: PubMed Mentions: 50
6. Stereotactic Body Radiation Therapy for Prostate Cancer: Review of Experience of a Multicenter Phase I/II Dose-Escalation Study. Front Oncol. 2014; 4:319. Kim DW, Straka C, Cho LC, Timmerman RD. PMID: 25505731; PMCID: PMC4245005.
   View in: PubMed Mentions: 17
7. Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2014 Jul 01; 89(3):509-17. Kim DW, Cho LC, Straka C, Christie A, Lotan Y, Pistenmaa D, Kavanagh BD, Nanda A, Kueplian P, Brindle J, Cooley S, Perkins A, Raben D, Xie XJ, Timmerman RD. PMID: 24929162.
8. Ablation of a site of progression with stereotactic body radiation therapy extends sunitinib treatment from 14 to 22 months. J Clin Oncol. 2013 Aug 10; 31(23):e401-3. Straka C, Kim DW, Timmerman RD, Pedrosa I, Jacobs C, Brugarolas J. PMID: 23796996; PMCID: PMC4878052.
   View in: PubMed Mentions: 12 Fields:
   Translation:Humans
9. Prolonged survival of a patient with papillary renal cell carcinoma and brain metastases using pazopanib. J Clin Oncol. 2013 Mar 01; 31(7):e114-7. Jacobs C, Kim DW, Straka C, Timmerman RD, Brugarolas J. PMID: 23319695.
   View in: PubMed Mentions: 17 Fields:
   Translation:Humans

This graph shows the total number of publications by year. To see the data as text, click here.

This graph shows the total number of publications by year. To return to the graph, click here.

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs

Concepts (58)

Derived automatically from this person's publications.

_

Co-Authors (4)

People in Profiles who have published with this person.

_

Similar People (60)

People who share similar concepts with this person.

_

Search Department

_